Search
Travere Therapeutics Inc
TVTXAdd to Watchlist
65.670USD
-1.850-2.74%
Close 08-28 16:00（ET）
5.97BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.74%
5 Days
-0.06%
1 Month
+18.20%
6 Months
+120.44%
Year to Date
+71.87%
1 Year
+275.26%
Key Figures
67.270Open
67.450High
55.66KVolume
LossP/E TTM
27.38P/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
67.520Prev. Close
65.370Low
3.69MTurnover
LossP/E Static
52.03P/B
0.00%Div Yield TTM
-8.27%ROA
67.85052wk High
0.04Volume Ratio
-321.55MNet Profit
92.40MShares
-0.2236EPS TTM
1.14Beta
-69.38%ROE
17.27052wk Low
2.86%Amplitude
96.45%Gross Margin
5.97BMarket Cap
3.42Reward/Risk
4.52%Risk Rate
Travere Therapeutics Inc's Score
-0.11vs previous score
Forecast8.67
Financial Health7.64
Technical4.68
Valuation Dimensions9.80
Institutional Confidence10.00
Risk Assessment5.51
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Travere Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.37/-0.14
Revenue / Forecast
169.58M/159.59M
Travere Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolTVTX
Number of employees385
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Janus Henderson Investors | 11.30% |
| BlackRock Institutional Trust Company, N.A. | 6.98% |
| Fidelity Management & Research Company LLC | 6.32% |
| State Street Investment Management (US) | 5.12% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.74% |
| Investment Advisor/Hedge Fund | 33.58% |
| Hedge Fund | 20.55% |
| Research Firm | 5.84% |
Related Instruments
-0.13%
+0.85%
-1.11%
-1.03%
-0.80%
-0.54%
-1.05%
-2.14%
-0.21%
-1.41%
-1.07%
-0.55%
-0.04%
+0.32%
+1.09%
-1.67%
-3.37%
0.00%
-3.35%
-0.25%Popular Instruments
53555.200
+8.000 (+0.01%)
29453.100
-118.100 (-0.40%)
7712.900
-6.400 (-0.08%)
14639.000
-81.000 (-0.55%)
65815.000
-339.000 (-0.51%)
6476.100
+47.300 (+0.74%)
83.090
-0.176 (-0.21%)
319.700
+5.120 (+1.63%)
217.550
-10.430 (-4.57%)
4453.900
-146.790 (-3.19%)
FAQs
What is the current price of Travere Therapeutics Inc (TVTX)?
The current price of Travere Therapeutics Inc (TVTX) is 65.67.
What is the symbol of Travere Therapeutics Inc?
The ticker symbol of Travere Therapeutics Inc is TVTX.
What is the 52-week high of Travere Therapeutics Inc?
The 52-week high of Travere Therapeutics Inc is 67.85.
What is the 52-week low of Travere Therapeutics Inc?
The 52-week low of Travere Therapeutics Inc is 17.27.
What is the market capitalization of Travere Therapeutics Inc?
The market capitalization of Travere Therapeutics Inc is 5.97B.
Is Travere Therapeutics Inc (TVTX) currently rated as Buy, Hold, or Sell?
According to analysts, Travere Therapeutics Inc (TVTX) has an overall rating of Buy, with a price target of 72.15.
What is the Earnings Per Share (EPS TTM) of Travere Therapeutics Inc (TVTX)?
The Earnings Per Share (EPS TTM) of Travere Therapeutics Inc (TVTX) is -0.22.